Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity Trial Among Adults Administered Quadrivalent Influenza Vaccine

NCT01218646 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.

NCT NCT01218646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity Trial Among Adults Administered Quadrivalent Influenza Vaccine
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
April 30, 2011
Enrollment
739 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

influenza